cdmo.directory
← Compare landing

AGC Biologics vs Cell and Gene Therapy Catapult

Side-by-side profile data from each company listing. Missing fields stay blank rather than filled with assumptions.

CategoryAGC BiologicsCell and Gene Therapy Catapult
SummaryGlobal CDMO offering development and manufacturing for protein expression biologics, pDNA, mRNA, viral vectors (AAV, LVV, RVV), and genetically engineered cells with scale-out manufacturing capabilities.UK-based innovation and manufacturing support organization for cell and gene therapies, offering infrastructure, expertise, and collaboration across the ATMP lifecycle.
Services
  • Biologics Development & Manufacturing
  • Monoclonal Antibody (mAb) Manufacturing
  • Recombinant Protein Manufacturing
  • Cell-Line Development
  • Upstream Processing
  • Downstream Processing
  • ADC (Antibody-Drug Conjugate) Manufacturing
  • Viral Vector Manufacturing
  • AAV Manufacturing
  • Lentiviral Vector Manufacturing
  • Cell Therapy Manufacturing
  • mRNA Manufacturing
  • Sterile Fill-Finish & Aseptic Manufacturing
  • Vial Filling
  • Prefilled Syringe (PFS) Filling
  • Process Development
  • Formulation Development
  • Technology Transfer
  • CMC Analytical Development
  • Quality Control Testing
  • CMC Regulatory Submission Support
  • Cell-Line Development
  • Upstream Processing
  • Downstream Processing
  • Viral Vector Manufacturing
  • AAV Manufacturing
  • Lentiviral Vector Manufacturing
  • Cell Therapy Manufacturing
  • Autologous Cell Therapy Manufacturing
  • Allogeneic Cell Therapy Manufacturing
  • Process Development
  • Technology Transfer
  • CMC Analytical Development
  • CMC Regulatory Submission Support
Modalities
  • Biologics (Monoclonal Antibodies)
  • Biologics (Other)
  • Antibody-Drug Conjugate (ADC)
  • mRNA
  • Cell Therapy
  • Gene Therapy
  • AAV / Viral Vector Platform
  • Cell Therapy
  • Gene Therapy
  • AAV / Viral Vector Platform
Development capabilities
  • Analytical method development
  • Formulation development
  • Cell line development
  • Analytical method development
  • Formulation development
  • Cell line development
Manufacturing capabilities
  • Drug Substance (DS)
  • Drug Product (DP)
  • Liquid Vials
  • Prefilled Syringes (PFS)
  • Max bioreactor: Mid-scale clinical (≤2,000 L)
  • Expression: Mammalian
  • Expression: Microbial
  • Expression: Viral Vector
  • Expression: Cell-Free
  • Single-Use / Disposable
  • Stainless Steel
  • Drug Substance (DS)
  • Drug Product (DP)
  • Expression: Mammalian
  • Expression: Viral Vector
  • Single-Use / Disposable
Locations
  • Headquarters, Seattle, Washington, USA
  • Copenhagen, Copenhagen, Denmark
  • Heidelberg, Heidelberg, Germany
  • Milan, Milan, Italy
  • Chiba, Chiba, Japan
  • Yokohama, Yokohama, Japan
  • Headquarters, Stevenage, Hertfordshire, United Kingdom
  • London, London, England, United Kingdom
  • Braintree, Braintree, Essex, United Kingdom
  • Edinburgh, Edinburgh, Scotland, United Kingdom
  • Headquarters, United Kingdom
CertificationsData not yet provided.Data not yet provided.

Find similar companies

AGC Biologics alternatives · Cell and Gene Therapy Catapult alternatives

Markdown mirror: /compare/agcbio/ct.md